Wei Lu

This inventor holds 39 USPTO granted patents and 24 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Mutant IDH Inhibitors. Top assignees: Forma Therapeutics, Inc., Forma Tm2, Inc., William Marsh Rice University. Active years: 2013-2025.

USPTO Granted Patents = 39 (Patent Applications = 24)

% Patents Active = 46.2

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 12 (Patent Applications = 10)

Average Co-Inventor Count = 7.4

ph-index = 11

Forward Citations = 299(Granted Patents)

Location History:

Bethesda, MD (US) (2013 - 2017)
Houston, TX (US) (2016 - 2019)
Newton, MA (US) (2017 - 2024)

Company Filing History:

29 out of 125

Forma Therapeutics, Inc.

William Marsh Rice University

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Mutant Isocitrate Dehydrogenase

FASN Inhibitors

Quinolinone Derivatives

Pyridin-2(1H)-one

Bicyclic Aryl Compounds

Heterocyclic Compounds

Nanocomposite Sensors

Graphene Nanoribbons

Wellbore Fluids

Hydrocarbon Detection

Magnetic Functionalized Carbon

Orthogonal Frequency Division

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275715 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2025-04-14),

2. 11963956 - Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) (2024-04-23),

3. 11738018 - Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) (2023-08-29),

4. 11576906 - Inhibiting mutant IDH-1 (2023-02-14),

5. 11498913 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2022-11-15),

6. 11497743 - Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation (2022-11-15),

7. 11376246 - Inhibiting mutant IDH-1 (2022-07-05),

8. 11311527 - Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) (2022-04-26),

9. 11013734 - Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation (2021-05-25),

10. 11013733 - Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1) (2021-05-25),

11. 10995078 - Compounds and compositions for inhibition of FASN (2021-05-04),

12. 10889567 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2021-01-12),

13. 10807976 - Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors (2020-10-20),

14. 10800750 - Compounds and compositions for inhibition of FASN (2020-10-13),

15. 10577329 - Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2020-03-03),

Title: The Innovative Mind of Wei Lu

Introduction: Wei Lu is a pioneering inventor based in Newton, MA, known for her groundbreaking contributions to the field of technology.

Latest Patents: Wei Lu holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing her continuous dedication to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Wei Lu has worked with top tech companies, leading research institutions, and universities, where she has spearheaded projects that have revolutionized the industry.

Collaborations: Wei Lu has collaborated with renowned engineers, scientists, and researchers from around the world, fostering a culture of creativity and excellence in all her endeavors.

Conclusion: Wei Lu's passion for innovation, coupled with her relentless drive to solve complex problems, solidifies her status as a trailblazing inventor shaping the future of technology.